Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial
- Silvio E. Inzucchi1⇑,
- Christoph Wanner2,
- Uwe Hehnke3,
- Isabella Zwiener3,
- Stefan Kaspers3,
- Douglas Clark3,
- Jyothis T. George3 and
- Bernard Zinman4
- 1Section of Endocrinology, Yale University School of Medicine, New Haven, CT
- 2Department of Medicine, Würzburg University Clinic, Würzburg, Germany
- 3Boehringer Ingelheim International GmbH, Ingelheim, Germany
- 4Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada
- Corresponding author: Silvio E. Inzucchi, silvio.inzucchi{at}yale.edu
Article Information
vol. 42 no. 4 e53-e55
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 25, 2018
- Accepted December 25, 2018
- Published in print March 20, 2019.
- Published online ahead of print January 31, 2019.
Article Versions
- Previous version (January 31, 2019 - 13:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Silvio E. Inzucchi1⇑,
- Christoph Wanner2,
- Uwe Hehnke3,
- Isabella Zwiener3,
- Stefan Kaspers3,
- Douglas Clark3,
- Jyothis T. George3 and
- Bernard Zinman4
- 1Section of Endocrinology, Yale University School of Medicine, New Haven, CT
- 2Department of Medicine, Würzburg University Clinic, Würzburg, Germany
- 3Boehringer Ingelheim International GmbH, Ingelheim, Germany
- 4Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada
- Corresponding author: Silvio E. Inzucchi, silvio.inzucchi{at}yale.edu
Statistics from Altmetric.com
Article usage
In this Issue
April 2019, 42(4)
Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial
